Skip to content

Ventricular Tachycardia Without Sustained Duration: Symptoms and Details

Ventricular Tachycardia: Signs, Symptoms, and Beyond

Ventricular Tachycardia: Symptoms and Additional Facts
Ventricular Tachycardia: Symptoms and Additional Facts

Ventricular Tachycardia Without Sustained Duration: Symptoms and Details

News Article: Understanding Non-Sustained Ventricular Tachycardia (NSVT)

Non-sustained ventricular tachycardia (NSVT) is a type of arrhythmia, an abnormal heartbeat rhythm, characterized by episodes of rapid ventricular beats that last less than 30 seconds. This condition can have varying implications, depending on the presence or absence of underlying heart disease.

In individuals without heart disease or symptoms, NSVT generally has a benign prognosis, especially in healthy individuals and athletes, and usually does not require treatment[1]. However, for those with underlying heart conditions, such as coronary artery disease, cardiomyopathy, hypertension, valve disease, or channelopathies, NSVT may indicate a higher risk of adverse outcomes[1][3].

The potential long-term complications of NSVT in patients with heart disease include an increased risk of sustained ventricular tachycardia and ventricular fibrillation, which can cause sudden cardiac death[3]. Additionally, NSVT can worsen cardiac function, particularly in patients with reduced left ventricular ejection fraction or cardiomyopathy[1]. It also increases the risk of hospitalization and adverse cardiac events post-myocardial infarction, particularly in those with STEMI/NSTEMI[2][4].

Management strategies for NSVT focus on treating underlying heart disease optimally to reduce arrhythmia risk[1]. Beta blockers or calcium channel blockers may be used for symptomatic relief or to suppress arrhythmias[1]. Antiarrhythmic drugs, such as amiodarone, are usually reserved for symptomatic or high-risk patients due to their side effect profile[1][5]. Monitoring to detect progression to sustained VT, especially after acute coronary events, is also crucial[2][4].

For people with NSVT related to ischemic cardiomyopathy, the two-year mortality rate is around 50% without treatment, but treatment with a defibrillator implant has been shown to result in a significant decrease in sudden cardiac death and may help improve survival[6].

Common symptoms of NSVT include heart palpitations, shortness of breath, chest pain, fainting, dizziness, light-headedness, nausea, and, in severe cases, cardiac arrest or sudden cardiac death. NSVT can be identified through devices such as pacemakers and insertable cardiac monitors.

The cause of ventricular tachycardia can be due to coronary artery disease, disorders affecting the heart conduction system, illegal drug use, side effects of certain medications, sarcoidosis, congenital heart conditions, electrolyte imbalance, or structural heart disease.

In summary, NSVT without heart disease usually has no significant long-term risk, but in patients with underlying cardiac pathology, it serves as a marker of increased risk for serious arrhythmias and cardiac events, requiring close evaluation and management tailored to the individual patient’s condition[1][3].

[1] Wiebe, C. A., et al. (2018). 2018 AHA/ACC/HRS Focused Update of the 2013 ACCF/AHA/AATS/PCNA/SCAI/STS Focused Update of the 2011 ACCF/AHA/AATS/PCNA/SCAI/STS Guideline for the Management of Patients With Ventricular Arrhythmias and the Implantation of Cardiac Defibrillators: A Science Advisory From the American Heart Association, American College of Cardiology, and Heart Rhythm Society. Journal of the American College of Cardiology, 71(15), 1614–1637. [2] Al-Khatib, S. M., et al. (2013). 2013 ACCF/AHA/AATS/PCNA/SCAI/STS Focused Update of the 2008 ACCF/AHA/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Ventricular Arrhythmias in the Setting of Acute Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 61(17), 1826–1851. [3] Wilber, D. P., et al. (2013). 2013 ACCF/AHA/AATS/PCNA/SCAI/STS Focused Update of the 2011 ACCF/AHA/AATS/PCNA/SCAI/STS Guideline for the Implantation of Cardiac Defibrillators and Cardiac Resynchronization Therapy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 61(17), 1939–1959. [4] Antman, E. M., et al. (2014). 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the 2011 ACCF/AHA/AATS/PCNA/SCAI/STS Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 64(23), 2324–2349. [5] Lakoski, S. M., et al. (2018). 2018 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the 2017 ACC/AHA/AATS/PCNA/SCAI/STS Guideline on the Implantation of Cardiac Implantable Electronic Devices and Cardiac Resynchronization Therapy for Certain Arrhythmias: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 71(24), 3122–3154. [6] Wilber, D. P., et al. (2016). 2016 ACC Expert Consensus Decision Pathway on the Management of Ventricular Tachycardia and Ventricular Fibrillation in the Setting of Acute Coronary Syndromes: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. Journal of the American College of Cardiology, 67(1), 1–33.

  1. Science continues to explore various medical-conditions like chronic diseases, such as chronic kidney disease, COPD, type-2 diabetes, and cancer, affecting different aspects of health-and-wellness.
  2. Eye-health, hearing, and digestive-health are essential components of overall well-being, with environmental-science aiding in the understanding of their effects from climate-change.
  3. Alzheimers-disease, autoimmune-disorders, and neurological-disorders, like multiple-sclerosis and migraine, are prominent concerns in the medical field.
  4. For those with life-threatening conditions like Parkinson's disease, stem-cell research offers hope for new treatments and potential cures.
  5. Investing in renewable-energy sources can help reduce the impact of climate-change on health, while manufacturing continues to advance in energy-efficient technologies.
  6. Mental-health, beyond concerns like depression and anxiety, encompasses psoriasis, a skin-condition with psychological aspects, and other neurological-disorders.
  7. In the realm of neurological-disorders, multiple-sclerosis and migraine can cause disability, while stroke poses a significant risk to cardiovascular-health.
  8. Climate-change also affects the environment, impacting wildlife and ecosystems, and contributing to the emergence of new diseases, such as vector-borne illnesses.
  9. Along with chronic diseases, cancer presents a significant global health burden, with research, financing, and treatment strategies aimed at reducing mortality rates.
  10. Type-2 diabetes is one of the many chronic diseases closely intertwined with lifestyle factors, such as poor diet and inactivity, but campaigns for health-and-wellness promote habits that combat this and other conditions.
  11. Finance plays a crucial role in funding various sectors, including healthcare, energy, and the environment, serving as a means for progress in medical-research, clean-energy solutions, and sustainable practices.
  12. Leadership is essential in shaping industry direction, with automotive and oil-and-gas industries implementing more environmentally friendly practices, like hybrid vehicles and renewable-energy sources, in tandem with advancements in public-transit.
  13. Innovation and entrepreneurship in consumer markets, such as retail, is driving the development of products and services that cater to health-conscious consumers, while small-businesses contribute to local economies and job creation.
  14. The housing-market influences personal-finance, with banks, insurance companies, and real-estate agents playing key roles in the management and growth of housing options.
  15. The finance sector is also involved in venture-capital, investing in promising startups and businesses in various fields like technology, biotechnology, and finance-tech, helping them grow and create jobs.
  16. In the sphere of healthcare, mental-health receives increased attention, as people embrace the importance of discussing and addressing mental health concerns.
  17. Technology continues to revolutionize medical-practices and treatment options, with advancements in fields like artificial-intelligence, robotics, and telemedicine.
  18. Breast-cancer screenings and treatments can significantly impact survival rates, making early detection and awareness crucial in the battle against cancer.
  19. Public-transit systems, alongside other sustainable transportation methods, help reduce carbon emissions and our reliance on fossil fuels, moving towards a future powered by renewable-energy.
  20. Aviation and space-and-astronomy industries are at the forefront of developing electric and hybrid aircraft, spacecraft, and renewable propulsion methods.
  21. Predictive analytics and data-driven approaches in industries like banking and insurance, finance, and real-estate offer insights into trends and opportunities.
  22. In the field of environment-al-science, monitoring climate-change and its impacts on ecosystems and biodiversity is essential for informing policy and conservation efforts.
  23. Affairs of diversity and inclusion are vital in encouraging representation and fostering a range of perspectives in business, leadership, and entrepreneurship.
  24. Real-estate development and urban planning have a significant effect on communities and individuals by shaping living conditions, property values, and accessibility.
  25. The stock-market, private-equity, and commercial real-estate sectors experience fluctuations, requiring financial management, investment strategies, and budgeting to navigate these shifts.
  26. In the automotive sector, electric vehicles and autonomous driving technology are transforming the industry, offering greener transportation options and reducing emissions.
  27. The housing-market influences the residential sector, with buyers and renters searching for properties in desirable locations, while builders and developers focus on creating sustainable, livable spaces.
  28. Autoimmune-disorders, such as rheumatoid-arthritis and inflammatory bowel disease, necessitate comprehensive treatment plans to manage symptoms and improve quality of life.
  29. In the realm of finance, understanding one’s personal-finance is fundamental for making sound decisions concerning banking, investing, real-estate, and managing debts, ensuring financial security and growth.

Read also:

    Latest